SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at SHF Holdings, Quince Therapeutics, Silo Pharma, and Upexi have recently purchased shares of their respective companies, signaling potential confidence in their future prospects. SHF Holdings and Upexi reported losses in their latest quarterly results, while Quince Therapeutics completed an acquisition and Silo Pharma entered into an exclusive license agreement.
December 08, 2023 | 1:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Quince Therapeutics Director David Lamond acquired shares following the successful completion of an acquisition, suggesting a positive outlook for the company.
The insider purchase coming after a successful acquisition could be seen as a bullish sign, potentially leading to a short-term positive impact on the stock.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
SHF Holdings insiders, including the Chief Legal Officer and CEO, purchased shares, despite a recent quarterly loss. This could indicate insider confidence in the company's future.
Insider purchases often signal confidence in the company's prospects, which may positively influence investor sentiment and potentially the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Silo Pharma's President and CEO bought shares after the company entered into an exclusive license agreement, which may be perceived as a positive development.
The CEO's purchase after entering into a license agreement could reflect optimism about the company's future, potentially affecting the stock positively.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Upexi's CEO acquired a significant number of shares after the company reported a wider-than-expected quarterly loss, which might suggest confidence in a turnaround.
Despite a wider-than-expected loss, the CEO's purchase could be seen as a vote of confidence in the company's recovery potential, possibly leading to a short-term positive impact on the stock.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70